| Net Cash Provided by (Used in) Operating Activities |
$38,125 |
USD |
-21% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$38,125 |
USD |
21% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
2,458,590 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,469,033 |
USD |
7.5% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$642,300 |
USD |
4.2% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$125,456 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
$192,339 |
USD |
14% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |